Anti-idiotypic opioid receptor antibodies.
Anti-idiotypic antibodies were raised against the monoclonal antibody 3-E7. One of these anti-idiotypic antibodies interferes with the binding of 3H-diprenorphine at solubilized opioid receptors, and exhibits opioid agonistic activity on NG108CC15 hybrid cells.